Verifying…
Home / Drug A–Z / Zanclotac-150 Tablets

Zanclotac-150 Tablets

NAFDAC Reg. No. A4-4389 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Zanclotac-150 Tablets
NAFDAC number
A4-4389
Active ingredient
Ranitidine (Ranitidine Hydrochloride)
Strength
150 mg
Form
Tablet
Manufacturer
Not listed
Applicant (holder)
Mayglow Pharmaceutical Limited
Approved
21 Dec 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
20 Dec 2025
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Zanclotac-150 Tablets is on the NAFDAC register with an active registration (A4-4389). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Zanclotac-150 Tablets is used for

From the official U.S. FDA label for ranitidine (ranitidine hydrochloride), the active ingredient registered with NAFDAC.

What it is used for

(s) relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Purpose

Acid reducer

Possible side effects

Stop use and ask doctor if your heartburn continues or worsens you need to take this product for more than 14 days

Do not use if

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor. with other acid reducers

Warnings

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor. with other acid reducers Ask a doctor before use if you have had heartburn over 3 months. This may be a sign of a more serious condition. …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Zanclotac-150 Tablets

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Zanclotac-150 Tablets

What is in Zanclotac-150 Tablets?

Zanclotac-150 Tablets contains Ranitidine (Ranitidine Hydrochloride) (150 mg), as tablet, according to its NAFDAC registration record.

Is Zanclotac-150 Tablets registered with NAFDAC?

Yes. Zanclotac-150 Tablets is listed on the NAFDAC register under registration number A4-4389, and its registration is active as of 5 November 2026.

Has Zanclotac-150 Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Zanclotac-150 Tablets in our automatically synced alert list.

How can I check that my pack of Zanclotac-150 Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-4389, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Zanclotac-150 Tablets used for?

(s) relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages (Summarised from the official U.S. FDA label for ranitidine (ranitidine hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Zanclotac-150 Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.